Suppr超能文献

比较术前缓解评分和糖尿病病程单独作为预测减重手术后 2 型糖尿病持续缓解和糖尿病并发症风险的指标:瑞典肥胖受试者研究参与者的事后分析。

Comparison of Preoperative Remission Scores and Diabetes Duration Alone as Predictors of Durable Type 2 Diabetes Remission and Risk of Diabetes Complications After Bariatric Surgery: A Post Hoc Analysis of Participants From the Swedish Obese Subjects Study.

机构信息

Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

出版信息

Diabetes Care. 2020 Nov;43(11):2804-2811. doi: 10.2337/dc20-0157. Epub 2020 Sep 1.

Abstract

OBJECTIVE

Bariatric surgery is associated with diabetes remission and prevention of diabetes-related complications. The ABCD, DiaRem, Ad-DiaRem, DiaBetter, and individualized metabolic surgery scores were developed to predict short- to medium-term diabetes remission after bariatric surgery. However, they have not been tested for predicting durable remission nor the risk of diabetes complications, nor compared with diabetes duration alone.

RESEARCH DESIGN AND METHODS

We identified 363 individuals from the surgically treated group in the prospective Swedish Obese Subjects study with preoperative type 2 diabetes and for whom data (preoperative age, BMI, C-peptide, HbA, oral diabetes medications, insulin use, and diabetes duration) were available for calculation of remission scores. Partial remission (after 2 and 10 years) was defined as blood glucose <6.1 mmol/L or HbA <6.5% (48 mmol/mol) and no diabetes medication. Information on diabetes complications (at baseline and over 15 years of follow-up) was obtained from national health registers. Discrimination was evaluated by area under receiver operating characteristic curves (AUROCs).

RESULTS

For 2-year diabetes remission, AUROCs were between 0.79 and 0.88 for remission scores and 0.84 for diabetes duration alone. After 10 years, the predictive ability of scores decreased markedly (AUROCs between 0.70 and 0.76), and no score had higher predictive capacity than diabetes duration alone (AUROC = 0.73). For development of microvascular and macrovascular diabetes complications over 15 years, AUROCs for remission scores were 0.70-0.80 and 0.62-0.71, respectively, and AUROCs for diabetes duration alone were 0.77 and 0.66, respectively.

CONCLUSIONS

Remission scores and diabetes duration are good predictors of short-term diabetes remission. However, for durable remission and risk of complications, remission scores and diabetes duration alone have limited predictive ability.

摘要

目的

减重手术可实现糖尿病缓解,并预防糖尿病相关并发症。ABCD、DiaRem、Ad-DiaRem、DiaBetter 和个体化代谢手术评分用于预测减重手术后短期至中期的糖尿病缓解。然而,这些评分尚未经过预测持久缓解和糖尿病并发症风险的检验,也未与糖尿病病程进行比较。

研究设计和方法

我们从前瞻性瑞典肥胖受试者研究的手术治疗组中确定了 363 名患有 2 型糖尿病的个体,他们具有术前数据(年龄、BMI、C 肽、HbA1c、口服糖尿病药物、胰岛素使用和糖尿病病程),可用于计算缓解评分。部分缓解(术后 2 年和 10 年)定义为血糖<6.1mmol/L 或 HbA1c<6.5%(48mmol/mol)且无需使用糖尿病药物。通过国家健康登记处获得糖尿病并发症(基线和 15 年随访期间)的信息。通过接受者操作特征曲线下面积(AUROC)评估区分度。

结果

对于 2 年的糖尿病缓解,缓解评分的 AUROC 为 0.79-0.88,而糖尿病病程的 AUROC 为 0.84。10 年后,评分的预测能力显著下降(AUROC 为 0.70-0.76),且没有评分比糖尿病病程本身具有更高的预测能力(AUROC=0.73)。对于 15 年期间微血管和大血管糖尿病并发症的发展,缓解评分的 AUROC 分别为 0.70-0.80 和 0.62-0.71,而糖尿病病程的 AUROC 分别为 0.77 和 0.66。

结论

缓解评分和糖尿病病程是短期糖尿病缓解的良好预测指标。然而,对于持久缓解和并发症风险,缓解评分和糖尿病病程本身的预测能力有限。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验